Skip to main content

CORRECTION article

Front. Endocrinol., 26 September 2024
Sec. Cellular Endocrinology
Volume 15 - 2024 | https://doi.org/10.3389/fendo.2024.1486498

Corrigendum: Alterations in cellular metabolism under different grades of glioma staging identified based on a multi-omics analysis strategy

This article is a correction to:

  1. Alterations in cellular metabolism under different grades of glioma staging identified based on a multi-omics analysis strategy

    1. Read original article
Xianlei Yan,&#x;Xianlei Yan1,2†Jinwei Li&#x;Jinwei Li1†Yang Zhang&#x;Yang Zhang3†Cong LiangCong Liang4Pengcheng LiangPengcheng Liang2Tao LiTao Li5Quan LiuQuan Liu2Xuhui Hui*Xuhui Hui1*
  • 1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
  • 2Department of Neurosurgery, Liuzhou Workers Hospital, Liuzhou, Guangxi, China
  • 3Department of Vascular Surgery, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, Yunnan, China
  • 4Department of Pharmacy, Liuzhou Workers Hospital, Liuzhou, Guangxi, China
  • 5Department of Medical Imaging, Liuzhou Workers Hospital, Liuzhou, Guangxi, China

A Corrigendum on:
Alterations in cellular metabolism under different grades of glioma staging identified based on a multi-omics analysis strategy

By Yan X, Li J, Zhang Y, Liang C, Liang P, Li T, Liu Q and Hui X (2023). Front. Endocrinol. 14:1292944. doi: 10.3389/fendo.2023.1292944

In the published article, there was an error in Supplementary Tables 1 and 3. The copied tables did not contain a reference to the original research paper that they were copied from Björkblom et al., 2022.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: multi-omics analysis, cellular metabolism, glioma, single-cell, biomarker

Citation: Yan X, Li J, Zhang Y, Liang C, Liang P, Li T, Liu Q and Hui X (2024) Corrigendum: Alterations in cellular metabolism under different grades of glioma staging identified based on a multi-omics analysis strategy. Front. Endocrinol. 15:1486498. doi: 10.3389/fendo.2024.1486498

Received: 26 August 2024; Accepted: 11 September 2024;
Published: 26 September 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Yan, Li, Zhang, Liang, Liang, Li, Liu and Hui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xuhui Hui, aHVpeHVodWl3Y0AxMjYuY29t

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.